Literature DB >> 16682561

Off-target effects by siRNA can induce toxic phenotype.

Yuriy Fedorov1, Emily M Anderson, Amanda Birmingham, Angela Reynolds, Jon Karpilow, Kathryn Robinson, Devin Leake, William S Marshall, Anastasia Khvorova.   

Abstract

Although recent microarray studies have provided evidence of RNA interference (RNAi)-mediated off-target gene modulation, little is known about whether these changes induce observable phenotypic outcomes. Here we show that a fraction of randomly selected small inhibitory RNAs (siRNAs) can induce changes in cell viability in a target-independent fashion. The observed toxicity requires an intact RNAi pathway and can be eliminated by the addition of chemical modifications that reduce off-target effects. Furthermore, an analysis of toxic and nontoxic duplexes identifies a strong correlation between the toxicity and the presence of a 4-base-pair motif (UGGC) in the RISC-entering strand of toxic siRNA. This article provides further evidence of siRNA-induced off-target effects generating a measurable phenotype and also provides an example of how such undesirable phenotypes can be mitigated by addition of chemical modifications to the siRNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682561      PMCID: PMC1484448          DOI: 10.1261/rna.28106

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  18 in total

1.  Expression profiling reveals off-target gene regulation by RNAi.

Authors:  Aimee L Jackson; Steven R Bartz; Janell Schelter; Sumire V Kobayashi; Julja Burchard; Mao Mao; Bin Li; Guy Cavet; Peter S Linsley
Journal:  Nat Biotechnol       Date:  2003-05-18       Impact factor: 54.908

2.  Rational siRNA design for RNA interference.

Authors:  Angela Reynolds; Devin Leake; Queta Boese; Stephen Scaringe; William S Marshall; Anastasia Khvorova
Journal:  Nat Biotechnol       Date:  2004-02-01       Impact factor: 54.908

3.  Kinetic analysis of the RNAi enzyme complex.

Authors:  Benjamin Haley; Phillip D Zamore
Journal:  Nat Struct Mol Biol       Date:  2004-05-30       Impact factor: 15.369

4.  Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing.

Authors:  Aimee L Jackson; Julja Burchard; Devin Leake; Angela Reynolds; Janell Schelter; Jie Guo; Jason M Johnson; Lee Lim; Jon Karpilow; Kim Nichols; William Marshall; Anastasia Khvorova; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

5.  Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1.

Authors:  F B Gao; C C Carson; T Levine; J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  Expression of a novel immediate early gene during 12-O-tetradecanoylphorbol-13-acetate-induced macrophagic differentiation of HL-60 cells.

Authors:  N Shimizu; M Ohta; C Fujiwara; J Sagara; N Mochizuki; T Oda; H Utiyama
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

7.  RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated regions using a novel ELISA-based assay.

Authors:  P H King
Journal:  Nucleic Acids Res       Date:  2000-04-01       Impact factor: 16.971

8.  Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs.

Authors:  T D Levine; F Gao; P H King; L G Andrews; J D Keene
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  RNA oligonucleotide synthesis via 5'-silyl-2'-orthoester chemistry.

Authors:  Stephanie A Hartsel; David E Kitchen; Stephen A Scaringe; William S Marshall
Journal:  Methods Mol Biol       Date:  2005

10.  Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

Authors:  Gunter Meister; Markus Landthaler; Agnieszka Patkaniowska; Yair Dorsett; Grace Teng; Thomas Tuschl
Journal:  Mol Cell       Date:  2004-07-23       Impact factor: 17.970

View more
  160 in total

Review 1.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

2.  Identification of c-Myb Target Genes in K562 Cells Reveals a Role for c-Myb as a Master Regulator.

Authors:  Petra Isabel Lorenzo; Elen Margrethe Brendeford; Siv Gilfillan; Alexey A Gavrilov; Marit Leedsak; Sergey V Razin; Ragnhild Eskeland; Thomas Sæther; Odd Stokke Gabrielsen
Journal:  Genes Cancer       Date:  2011-08

3.  RNAimmuno: a database of the nonspecific immunological effects of RNA interference and microRNA reagents.

Authors:  Marta Olejniczak; Paulina Galka-Marciniak; Katarzyna Polak; Andrzej Fligier; Wlodzimierz J Krzyzosiak
Journal:  RNA       Date:  2012-03-12       Impact factor: 4.942

4.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

5.  Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease.

Authors:  Ryan L Boudreau; Ryan M Spengler; Beverly L Davidson
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

6.  Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells.

Authors:  Shun-Fa Yang; Mu-Kuan Chen; Yih-Shou Hsieh; Tsung-Te Chung; Yi-Hsien Hsieh; Chiao-Wen Lin; Jen-Liang Su; Ming-Hsui Tsai; Chih-Hsin Tang
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

Review 7.  The New State of the Art: Cas9 for Gene Activation and Repression.

Authors:  Marie F La Russa; Lei S Qi
Journal:  Mol Cell Biol       Date:  2015-09-14       Impact factor: 4.272

Review 8.  Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.

Authors:  Andrew B Hill; Mingfu Chen; Chih-Kuang Chen; Blaine A Pfeifer; Charles H Jones
Journal:  Trends Biotechnol       Date:  2015-12-23       Impact factor: 19.536

9.  Amelioration of colorectal cancer using negative lipidoid nanoparticles to encapsulate siRNA against APRIL by enema delivery mode.

Authors:  Weifeng Ding; Guihua Wang; Keke Shao; Feng Wang; Hua Huang; Shaoqing Ju; Hui Cong; Huimin Wang
Journal:  Pathol Oncol Res       Date:  2014-04-26       Impact factor: 3.201

10.  Differential toll-like receptor activation in lung ischemia reperfusion injury.

Authors:  Patrick Phelan; Heather E Merry; Billanna Hwang; Michael S Mulligan
Journal:  J Thorac Cardiovasc Surg       Date:  2015-02-28       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.